| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698335 | Clinical Oncology | 2017 | 9 Pages |
Abstract
This review highlights a lack of consensus in target volume definitions in carotid-sparing IMRT. Ultimately, long-term prospective data are required to show the benefit of carotid-sparing IMRT. Pooled data will prove useful as most studies will report on small numbers of patients. Therefore, adopting a consensus now on target volume definition, dose constraints and dose reporting will be crucial.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
D.M. Gujral, M. Long, J.W.G. Roe, K.J. Harrington, C.M. Nutting,